95 related articles for article (PubMed ID: 21962416)
1. Activity with ambulation attenuates diuretic responsiveness in chronic heart failure.
Galiwango PJ; McReynolds A; Ivanov J; Chan CT; Floras JS
J Card Fail; 2011 Oct; 17(10):797-803. PubMed ID: 21962416
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
3. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
4. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
6. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
Minutolo R; Andreucci M; Balletta MM; Russo D
Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
9. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
11. [Effect of posture on the diuretic treatment of decompensated cirrhosis and heart failure].
Wilken-Jensen C; Ring-Larsen H; Henriksen JH; Clausen J; Pals H; Christensen NJ
Ugeskr Laeger; 1989 Jan; 151(1):13-5. PubMed ID: 2911877
[TBL] [Abstract][Full Text] [Related]
12. Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure.
Khouzam RN; Nelson MD; Klemis JE; Wall BM; Mangold TA; Weber KT
Am J Med Sci; 2006 Jul; 332(1):1-5. PubMed ID: 16845234
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
15. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T
J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
